A comparative study to see the result of remdesevir in moderate and severe patients of covid 19

Abstract

Introduction : Till date for covid 19 infection no specific drug has been developed. This study was taken up to see the effect of remdesevir in moderate and severe covid cases.
Materials and Methods: 22 diagnosed patients of covid 19 in moderate and severe category were included in the study and divived in two groups of 11 patients each. Group a received only symptomatic treatment and other group B received injection remdesevir for 5 days along with symptomatic treatment.